InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,487.03
(
0.25%
)
US TECH 100
19,430.40
(
0.14%
)
Dow Jones
38,834.86
(
0.15%
)
Brent Oil
84.57
(
-0.15%
)
Bitcoin
65,112.02
(
0.22%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

JJM760

Send PM Follow Ignore
Followers 5
Posts 993
Boards Moderated 0
Alias Born 06/15/2010

JJM760

Re: adreamer post# 19381

Monday, 06/04/2012 2:32:49 PM

Monday, June 04, 2012 2:32:49 PM

Post# of 80490
Would you be so kind as to pass that "next front line molecule" stuff on to the insurance companies who will fight tooth and nail to make sure that title is given to generic Gleevec for as long as humanly possible.

The fight for the front line will be a difficult one regardless of the fact that Ponatinib is most likely as we speak best in class.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up